nodes	percent_of_prediction	percent_of_DWPC	metapath
Timolol—ABCB1—esophageal cancer	0.694	1	CbGaD
Timolol—Corneal disorder—Capecitabine—esophageal cancer	0.0107	0.0513	CcSEcCtD
Timolol—Fibrosis—Cisplatin—esophageal cancer	0.00586	0.0281	CcSEcCtD
Timolol—Memory loss—Cisplatin—esophageal cancer	0.0057	0.0273	CcSEcCtD
Timolol—Punctate keratitis—Capecitabine—esophageal cancer	0.00489	0.0234	CcSEcCtD
Timolol—Fibrosis—Capecitabine—esophageal cancer	0.00432	0.0207	CcSEcCtD
Timolol—Coronary artery disease—Cisplatin—esophageal cancer	0.00424	0.0203	CcSEcCtD
Timolol—Scab—Capecitabine—esophageal cancer	0.00388	0.0186	CcSEcCtD
Timolol—Bronchial hyperreactivity—Methotrexate—esophageal cancer	0.00352	0.0169	CcSEcCtD
Timolol—Arterial thrombosis—Methotrexate—esophageal cancer	0.00341	0.0163	CcSEcCtD
Timolol—Chronic obstructive pulmonary disease—Methotrexate—esophageal cancer	0.00321	0.0154	CcSEcCtD
Timolol—Fibrosis—Methotrexate—esophageal cancer	0.00321	0.0154	CcSEcCtD
Timolol—Rales—Capecitabine—esophageal cancer	0.00301	0.0144	CcSEcCtD
Timolol—Peripheral coldness—Capecitabine—esophageal cancer	0.00259	0.0124	CcSEcCtD
Timolol—Rales—Methotrexate—esophageal cancer	0.00224	0.0107	CcSEcCtD
Timolol—Visual acuity reduced—Capecitabine—esophageal cancer	0.00207	0.00993	CcSEcCtD
Timolol—Rhinorrhoea—Cisplatin—esophageal cancer	0.00207	0.00989	CcSEcCtD
Timolol—Infection—Carboplatin—esophageal cancer	0.00202	0.00969	CcSEcCtD
Timolol—Raised liver function tests—Methotrexate—esophageal cancer	0.00199	0.00953	CcSEcCtD
Timolol—Respiratory distress—Capecitabine—esophageal cancer	0.00194	0.0093	CcSEcCtD
Timolol—Keratitis—Capecitabine—esophageal cancer	0.0019	0.00911	CcSEcCtD
Timolol—Pharyngolaryngeal pain—Capecitabine—esophageal cancer	0.00183	0.00875	CcSEcCtD
Timolol—Laryngeal pain—Capecitabine—esophageal cancer	0.00181	0.00867	CcSEcCtD
Timolol—Hepatomegaly—Capecitabine—esophageal cancer	0.00174	0.00835	CcSEcCtD
Timolol—Pain—Carboplatin—esophageal cancer	0.00174	0.00834	CcSEcCtD
Timolol—Throat sore—Capecitabine—esophageal cancer	0.00171	0.0082	CcSEcCtD
Timolol—Oropharyngeal discomfort—Capecitabine—esophageal cancer	0.0017	0.00813	CcSEcCtD
Timolol—Rash erythematous—Capecitabine—esophageal cancer	0.00161	0.00772	CcSEcCtD
Timolol—Body temperature increased—Carboplatin—esophageal cancer	0.00161	0.00771	CcSEcCtD
Timolol—Rhinorrhoea—Capecitabine—esophageal cancer	0.00152	0.00729	CcSEcCtD
Timolol—Psoriasis—Methotrexate—esophageal cancer	0.00146	0.007	CcSEcCtD
Timolol—Eye irritation—Capecitabine—esophageal cancer	0.00145	0.00692	CcSEcCtD
Timolol—Oropharyngeal pain—Capecitabine—esophageal cancer	0.00136	0.0065	CcSEcCtD
Timolol—Cardiac failure congestive—Cisplatin—esophageal cancer	0.00134	0.00642	CcSEcCtD
Timolol—Lacrimation increased—Capecitabine—esophageal cancer	0.00134	0.00641	CcSEcCtD
Timolol—Nasal congestion—Cisplatin—esophageal cancer	0.00133	0.00639	CcSEcCtD
Timolol—Cataract—Capecitabine—esophageal cancer	0.0013	0.00621	CcSEcCtD
Timolol—Amnesia—Cisplatin—esophageal cancer	0.00129	0.00619	CcSEcCtD
Timolol—Cerebrovascular accident—Cisplatin—esophageal cancer	0.00124	0.00594	CcSEcCtD
Timolol—Blood pressure increased—Capecitabine—esophageal cancer	0.00123	0.00591	CcSEcCtD
Timolol—Dry eye—Capecitabine—esophageal cancer	0.00114	0.00546	CcSEcCtD
Timolol—Breast disorder—Cisplatin—esophageal cancer	0.0011	0.00526	CcSEcCtD
Timolol—Nasopharyngitis—Cisplatin—esophageal cancer	0.00109	0.0052	CcSEcCtD
Timolol—Abnormal vision—Capecitabine—esophageal cancer	0.00108	0.00515	CcSEcCtD
Timolol—Eye pain—Capecitabine—esophageal cancer	0.000992	0.00475	CcSEcCtD
Timolol—Libido decreased—Capecitabine—esophageal cancer	0.000966	0.00463	CcSEcCtD
Timolol—Amnesia—Capecitabine—esophageal cancer	0.000953	0.00457	CcSEcCtD
Timolol—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000949	0.00455	CcSEcCtD
Timolol—Respiratory failure—Methotrexate—esophageal cancer	0.000936	0.00448	CcSEcCtD
Timolol—Cardiac failure—Capecitabine—esophageal cancer	0.000918	0.0044	CcSEcCtD
Timolol—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000914	0.00438	CcSEcCtD
Timolol—Conjunctivitis—Cisplatin—esophageal cancer	0.00091	0.00436	CcSEcCtD
Timolol—Osteoarthritis—Capecitabine—esophageal cancer	0.000896	0.00429	CcSEcCtD
Timolol—Pain in extremity—Capecitabine—esophageal cancer	0.000896	0.00429	CcSEcCtD
Timolol—Diplopia—Capecitabine—esophageal cancer	0.000896	0.00429	CcSEcCtD
Timolol—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000889	0.00426	CcSEcCtD
Timolol—Bradycardia—Cisplatin—esophageal cancer	0.000856	0.0041	CcSEcCtD
Timolol—Cardiac arrest—Capecitabine—esophageal cancer	0.000852	0.00408	CcSEcCtD
Timolol—Mood swings—Capecitabine—esophageal cancer	0.000849	0.00406	CcSEcCtD
Timolol—Liver function test abnormal—Capecitabine—esophageal cancer	0.000827	0.00396	CcSEcCtD
Timolol—Connective tissue disorder—Cisplatin—esophageal cancer	0.000826	0.00396	CcSEcCtD
Timolol—Abdominal pain upper—Capecitabine—esophageal cancer	0.000818	0.00392	CcSEcCtD
Timolol—Pulmonary oedema—Methotrexate—esophageal cancer	0.000818	0.00392	CcSEcCtD
Timolol—Visual impairment—Cisplatin—esophageal cancer	0.00081	0.00388	CcSEcCtD
Timolol—Breast disorder—Capecitabine—esophageal cancer	0.00081	0.00388	CcSEcCtD
Timolol—Nasopharyngitis—Capecitabine—esophageal cancer	0.000801	0.00384	CcSEcCtD
Timolol—Eye disorder—Cisplatin—esophageal cancer	0.000786	0.00376	CcSEcCtD
Timolol—Tinnitus—Cisplatin—esophageal cancer	0.000784	0.00375	CcSEcCtD
Timolol—Cardiac disorder—Cisplatin—esophageal cancer	0.00078	0.00374	CcSEcCtD
Timolol—Asthma—Capecitabine—esophageal cancer	0.000774	0.00371	CcSEcCtD
Timolol—Bronchospasm—Capecitabine—esophageal cancer	0.000762	0.00365	CcSEcCtD
Timolol—Immune system disorder—Cisplatin—esophageal cancer	0.000759	0.00364	CcSEcCtD
Timolol—Mediastinal disorder—Cisplatin—esophageal cancer	0.000758	0.00363	CcSEcCtD
Timolol—Angina pectoris—Capecitabine—esophageal cancer	0.000754	0.00361	CcSEcCtD
Timolol—Arrhythmia—Cisplatin—esophageal cancer	0.000751	0.0036	CcSEcCtD
Timolol—Alopecia—Cisplatin—esophageal cancer	0.000743	0.00356	CcSEcCtD
Timolol—Erythema—Cisplatin—esophageal cancer	0.000732	0.0035	CcSEcCtD
Timolol—Malnutrition—Cisplatin—esophageal cancer	0.000732	0.0035	CcSEcCtD
Timolol—Dysuria—Capecitabine—esophageal cancer	0.000724	0.00347	CcSEcCtD
Timolol—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00072	0.00345	CcSEcCtD
Timolol—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000707	0.00338	CcSEcCtD
Timolol—Visual disturbance—Methotrexate—esophageal cancer	0.000704	0.00337	CcSEcCtD
Timolol—Weight decreased—Capecitabine—esophageal cancer	0.0007	0.00335	CcSEcCtD
Timolol—Hyperglycaemia—Capecitabine—esophageal cancer	0.000698	0.00334	CcSEcCtD
Timolol—Vision blurred—Cisplatin—esophageal cancer	0.00069	0.0033	CcSEcCtD
Timolol—Depression—Capecitabine—esophageal cancer	0.000688	0.0033	CcSEcCtD
Timolol—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000681	0.00326	CcSEcCtD
Timolol—Conjunctivitis—Capecitabine—esophageal cancer	0.000671	0.00321	CcSEcCtD
Timolol—Osteoarthritis—Methotrexate—esophageal cancer	0.000667	0.00319	CcSEcCtD
Timolol—Epistaxis—Capecitabine—esophageal cancer	0.000651	0.00312	CcSEcCtD
Timolol—Agranulocytosis—Capecitabine—esophageal cancer	0.000644	0.00308	CcSEcCtD
Timolol—Mood swings—Methotrexate—esophageal cancer	0.000632	0.00303	CcSEcCtD
Timolol—Bradycardia—Capecitabine—esophageal cancer	0.000631	0.00302	CcSEcCtD
Timolol—Myalgia—Cisplatin—esophageal cancer	0.000623	0.00298	CcSEcCtD
Timolol—Rhinitis—Capecitabine—esophageal cancer	0.000621	0.00297	CcSEcCtD
Timolol—Anxiety—Cisplatin—esophageal cancer	0.000621	0.00297	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000619	0.00296	CcSEcCtD
Timolol—Liver function test abnormal—Methotrexate—esophageal cancer	0.000616	0.00295	CcSEcCtD
Timolol—Discomfort—Cisplatin—esophageal cancer	0.000616	0.00295	CcSEcCtD
Timolol—Oedema peripheral—Capecitabine—esophageal cancer	0.00061	0.00292	CcSEcCtD
Timolol—Connective tissue disorder—Capecitabine—esophageal cancer	0.000609	0.00292	CcSEcCtD
Timolol—Breast disorder—Methotrexate—esophageal cancer	0.000603	0.00289	CcSEcCtD
Timolol—Oedema—Cisplatin—esophageal cancer	0.000597	0.00286	CcSEcCtD
Timolol—Anaphylactic shock—Cisplatin—esophageal cancer	0.000597	0.00286	CcSEcCtD
Timolol—Visual impairment—Capecitabine—esophageal cancer	0.000597	0.00286	CcSEcCtD
Timolol—Infection—Cisplatin—esophageal cancer	0.000593	0.00284	CcSEcCtD
Timolol—Nervous system disorder—Cisplatin—esophageal cancer	0.000586	0.0028	CcSEcCtD
Timolol—Skin disorder—Cisplatin—esophageal cancer	0.00058	0.00278	CcSEcCtD
Timolol—Eye disorder—Capecitabine—esophageal cancer	0.000579	0.00277	CcSEcCtD
Timolol—Tinnitus—Capecitabine—esophageal cancer	0.000578	0.00277	CcSEcCtD
Timolol—Hyperhidrosis—Cisplatin—esophageal cancer	0.000577	0.00276	CcSEcCtD
Timolol—Asthma—Methotrexate—esophageal cancer	0.000576	0.00276	CcSEcCtD
Timolol—Cardiac disorder—Capecitabine—esophageal cancer	0.000575	0.00275	CcSEcCtD
Timolol—Anorexia—Cisplatin—esophageal cancer	0.000569	0.00273	CcSEcCtD
Timolol—Angiopathy—Capecitabine—esophageal cancer	0.000562	0.00269	CcSEcCtD
Timolol—Immune system disorder—Capecitabine—esophageal cancer	0.00056	0.00268	CcSEcCtD
Timolol—Mediastinal disorder—Capecitabine—esophageal cancer	0.000559	0.00267	CcSEcCtD
Timolol—Hypotension—Cisplatin—esophageal cancer	0.000558	0.00267	CcSEcCtD
Timolol—Arrhythmia—Capecitabine—esophageal cancer	0.000554	0.00265	CcSEcCtD
Timolol—Alopecia—Capecitabine—esophageal cancer	0.000548	0.00262	CcSEcCtD
Timolol—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000544	0.00261	CcSEcCtD
Timolol—Mental disorder—Capecitabine—esophageal cancer	0.000543	0.0026	CcSEcCtD
Timolol—Erythema—Capecitabine—esophageal cancer	0.000539	0.00258	CcSEcCtD
Timolol—Malnutrition—Capecitabine—esophageal cancer	0.000539	0.00258	CcSEcCtD
Timolol—Dysuria—Methotrexate—esophageal cancer	0.000539	0.00258	CcSEcCtD
Timolol—Paraesthesia—Cisplatin—esophageal cancer	0.000536	0.00257	CcSEcCtD
Timolol—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000536	0.00257	CcSEcCtD
Timolol—Dyspnoea—Cisplatin—esophageal cancer	0.000532	0.00255	CcSEcCtD
Timolol—Erectile dysfunction—Methotrexate—esophageal cancer	0.000531	0.00254	CcSEcCtD
Timolol—Dysgeusia—Capecitabine—esophageal cancer	0.000528	0.00253	CcSEcCtD
Timolol—Decreased appetite—Cisplatin—esophageal cancer	0.000519	0.00249	CcSEcCtD
Timolol—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000516	0.00247	CcSEcCtD
Timolol—Depression—Methotrexate—esophageal cancer	0.000512	0.00245	CcSEcCtD
Timolol—Pain—Cisplatin—esophageal cancer	0.000511	0.00245	CcSEcCtD
Timolol—Vision blurred—Capecitabine—esophageal cancer	0.000508	0.00243	CcSEcCtD
Timolol—Conjunctivitis—Methotrexate—esophageal cancer	0.0005	0.00239	CcSEcCtD
Timolol—Sweating—Methotrexate—esophageal cancer	0.000493	0.00236	CcSEcCtD
Timolol—Feeling abnormal—Cisplatin—esophageal cancer	0.000492	0.00236	CcSEcCtD
Timolol—Epistaxis—Methotrexate—esophageal cancer	0.000485	0.00232	CcSEcCtD
Timolol—Vertigo—Capecitabine—esophageal cancer	0.000485	0.00232	CcSEcCtD
Timolol—Syncope—Capecitabine—esophageal cancer	0.000484	0.00232	CcSEcCtD
Timolol—Agranulocytosis—Methotrexate—esophageal cancer	0.00048	0.0023	CcSEcCtD
Timolol—Palpitations—Capecitabine—esophageal cancer	0.000477	0.00228	CcSEcCtD
Timolol—Loss of consciousness—Capecitabine—esophageal cancer	0.000474	0.00227	CcSEcCtD
Timolol—Body temperature increased—Cisplatin—esophageal cancer	0.000472	0.00226	CcSEcCtD
Timolol—Cough—Capecitabine—esophageal cancer	0.000471	0.00225	CcSEcCtD
Timolol—Hypertension—Capecitabine—esophageal cancer	0.000466	0.00223	CcSEcCtD
Timolol—Chest pain—Capecitabine—esophageal cancer	0.000459	0.0022	CcSEcCtD
Timolol—Myalgia—Capecitabine—esophageal cancer	0.000459	0.0022	CcSEcCtD
Timolol—Arthralgia—Capecitabine—esophageal cancer	0.000459	0.0022	CcSEcCtD
Timolol—Anxiety—Capecitabine—esophageal cancer	0.000458	0.00219	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000456	0.00218	CcSEcCtD
Timolol—Discomfort—Capecitabine—esophageal cancer	0.000454	0.00217	CcSEcCtD
Timolol—Dry mouth—Capecitabine—esophageal cancer	0.000449	0.00215	CcSEcCtD
Timolol—Visual impairment—Methotrexate—esophageal cancer	0.000445	0.00213	CcSEcCtD
Timolol—Confusional state—Capecitabine—esophageal cancer	0.000444	0.00213	CcSEcCtD
Timolol—Oedema—Capecitabine—esophageal cancer	0.00044	0.00211	CcSEcCtD
Timolol—Hypersensitivity—Cisplatin—esophageal cancer	0.00044	0.00211	CcSEcCtD
Timolol—Infection—Capecitabine—esophageal cancer	0.000437	0.00209	CcSEcCtD
Timolol—Shock—Capecitabine—esophageal cancer	0.000433	0.00207	CcSEcCtD
Timolol—Nervous system disorder—Capecitabine—esophageal cancer	0.000432	0.00207	CcSEcCtD
Timolol—Eye disorder—Methotrexate—esophageal cancer	0.000431	0.00206	CcSEcCtD
Timolol—Tinnitus—Methotrexate—esophageal cancer	0.00043	0.00206	CcSEcCtD
Timolol—Asthenia—Cisplatin—esophageal cancer	0.000429	0.00205	CcSEcCtD
Timolol—Cardiac disorder—Methotrexate—esophageal cancer	0.000428	0.00205	CcSEcCtD
Timolol—Skin disorder—Capecitabine—esophageal cancer	0.000428	0.00205	CcSEcCtD
Timolol—Hyperhidrosis—Capecitabine—esophageal cancer	0.000426	0.00204	CcSEcCtD
Timolol—Anorexia—Capecitabine—esophageal cancer	0.00042	0.00201	CcSEcCtD
Timolol—Angiopathy—Methotrexate—esophageal cancer	0.000419	0.002	CcSEcCtD
Timolol—Immune system disorder—Methotrexate—esophageal cancer	0.000417	0.002	CcSEcCtD
Timolol—Mediastinal disorder—Methotrexate—esophageal cancer	0.000416	0.00199	CcSEcCtD
Timolol—Hypotension—Capecitabine—esophageal cancer	0.000411	0.00197	CcSEcCtD
Timolol—Diarrhoea—Cisplatin—esophageal cancer	0.000409	0.00196	CcSEcCtD
Timolol—Alopecia—Methotrexate—esophageal cancer	0.000408	0.00195	CcSEcCtD
Timolol—Mental disorder—Methotrexate—esophageal cancer	0.000404	0.00194	CcSEcCtD
Timolol—Erythema—Methotrexate—esophageal cancer	0.000402	0.00192	CcSEcCtD
Timolol—Malnutrition—Methotrexate—esophageal cancer	0.000402	0.00192	CcSEcCtD
Timolol—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000401	0.00192	CcSEcCtD
Timolol—Insomnia—Capecitabine—esophageal cancer	0.000398	0.00191	CcSEcCtD
Timolol—Paraesthesia—Capecitabine—esophageal cancer	0.000395	0.00189	CcSEcCtD
Timolol—Dysgeusia—Methotrexate—esophageal cancer	0.000393	0.00188	CcSEcCtD
Timolol—Dyspnoea—Capecitabine—esophageal cancer	0.000393	0.00188	CcSEcCtD
Timolol—Dyspepsia—Capecitabine—esophageal cancer	0.000388	0.00186	CcSEcCtD
Timolol—Decreased appetite—Capecitabine—esophageal cancer	0.000383	0.00183	CcSEcCtD
Timolol—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00038	0.00182	CcSEcCtD
Timolol—Vomiting—Cisplatin—esophageal cancer	0.00038	0.00182	CcSEcCtD
Timolol—Fatigue—Capecitabine—esophageal cancer	0.00038	0.00182	CcSEcCtD
Timolol—Vision blurred—Methotrexate—esophageal cancer	0.000378	0.00181	CcSEcCtD
Timolol—Rash—Cisplatin—esophageal cancer	0.000377	0.0018	CcSEcCtD
Timolol—Pain—Capecitabine—esophageal cancer	0.000377	0.0018	CcSEcCtD
Timolol—Dermatitis—Cisplatin—esophageal cancer	0.000376	0.0018	CcSEcCtD
Timolol—Feeling abnormal—Capecitabine—esophageal cancer	0.000363	0.00174	CcSEcCtD
Timolol—Vertigo—Methotrexate—esophageal cancer	0.000361	0.00173	CcSEcCtD
Timolol—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00036	0.00172	CcSEcCtD
Timolol—Nausea—Cisplatin—esophageal cancer	0.000355	0.0017	CcSEcCtD
Timolol—Cough—Methotrexate—esophageal cancer	0.00035	0.00168	CcSEcCtD
Timolol—Urticaria—Capecitabine—esophageal cancer	0.00035	0.00167	CcSEcCtD
Timolol—Body temperature increased—Capecitabine—esophageal cancer	0.000348	0.00167	CcSEcCtD
Timolol—Abdominal pain—Capecitabine—esophageal cancer	0.000348	0.00167	CcSEcCtD
Timolol—Chest pain—Methotrexate—esophageal cancer	0.000342	0.00164	CcSEcCtD
Timolol—Myalgia—Methotrexate—esophageal cancer	0.000342	0.00164	CcSEcCtD
Timolol—Arthralgia—Methotrexate—esophageal cancer	0.000342	0.00164	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00034	0.00163	CcSEcCtD
Timolol—Discomfort—Methotrexate—esophageal cancer	0.000338	0.00162	CcSEcCtD
Timolol—Confusional state—Methotrexate—esophageal cancer	0.00033	0.00158	CcSEcCtD
Timolol—Anaphylactic shock—Methotrexate—esophageal cancer	0.000328	0.00157	CcSEcCtD
Timolol—Infection—Methotrexate—esophageal cancer	0.000326	0.00156	CcSEcCtD
Timolol—Hypersensitivity—Capecitabine—esophageal cancer	0.000324	0.00155	CcSEcCtD
Timolol—Nervous system disorder—Methotrexate—esophageal cancer	0.000321	0.00154	CcSEcCtD
Timolol—Skin disorder—Methotrexate—esophageal cancer	0.000318	0.00152	CcSEcCtD
Timolol—Hyperhidrosis—Methotrexate—esophageal cancer	0.000317	0.00152	CcSEcCtD
Timolol—Asthenia—Capecitabine—esophageal cancer	0.000316	0.00151	CcSEcCtD
Timolol—Anorexia—Methotrexate—esophageal cancer	0.000312	0.0015	CcSEcCtD
Timolol—Pruritus—Capecitabine—esophageal cancer	0.000311	0.00149	CcSEcCtD
Timolol—Hypotension—Methotrexate—esophageal cancer	0.000306	0.00147	CcSEcCtD
Timolol—Diarrhoea—Capecitabine—esophageal cancer	0.000301	0.00144	CcSEcCtD
Timolol—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000299	0.00143	CcSEcCtD
Timolol—Insomnia—Methotrexate—esophageal cancer	0.000296	0.00142	CcSEcCtD
Timolol—Paraesthesia—Methotrexate—esophageal cancer	0.000294	0.00141	CcSEcCtD
Timolol—Dyspnoea—Methotrexate—esophageal cancer	0.000292	0.0014	CcSEcCtD
Timolol—Somnolence—Methotrexate—esophageal cancer	0.000291	0.0014	CcSEcCtD
Timolol—Dizziness—Capecitabine—esophageal cancer	0.000291	0.00139	CcSEcCtD
Timolol—Dyspepsia—Methotrexate—esophageal cancer	0.000289	0.00138	CcSEcCtD
Timolol—Decreased appetite—Methotrexate—esophageal cancer	0.000285	0.00136	CcSEcCtD
Timolol—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000283	0.00135	CcSEcCtD
Timolol—Fatigue—Methotrexate—esophageal cancer	0.000283	0.00135	CcSEcCtD
Timolol—Pain—Methotrexate—esophageal cancer	0.00028	0.00134	CcSEcCtD
Timolol—Vomiting—Capecitabine—esophageal cancer	0.00028	0.00134	CcSEcCtD
Timolol—Rash—Capecitabine—esophageal cancer	0.000278	0.00133	CcSEcCtD
Timolol—Dermatitis—Capecitabine—esophageal cancer	0.000277	0.00133	CcSEcCtD
Timolol—Headache—Capecitabine—esophageal cancer	0.000276	0.00132	CcSEcCtD
Timolol—Feeling abnormal—Methotrexate—esophageal cancer	0.00027	0.00129	CcSEcCtD
Timolol—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000268	0.00128	CcSEcCtD
Timolol—Nausea—Capecitabine—esophageal cancer	0.000262	0.00125	CcSEcCtD
Timolol—Urticaria—Methotrexate—esophageal cancer	0.00026	0.00125	CcSEcCtD
Timolol—Abdominal pain—Methotrexate—esophageal cancer	0.000259	0.00124	CcSEcCtD
Timolol—Body temperature increased—Methotrexate—esophageal cancer	0.000259	0.00124	CcSEcCtD
Timolol—Hypersensitivity—Methotrexate—esophageal cancer	0.000241	0.00116	CcSEcCtD
Timolol—Asthenia—Methotrexate—esophageal cancer	0.000235	0.00113	CcSEcCtD
Timolol—Pruritus—Methotrexate—esophageal cancer	0.000232	0.00111	CcSEcCtD
Timolol—Diarrhoea—Methotrexate—esophageal cancer	0.000224	0.00107	CcSEcCtD
Timolol—Dizziness—Methotrexate—esophageal cancer	0.000217	0.00104	CcSEcCtD
Timolol—Vomiting—Methotrexate—esophageal cancer	0.000208	0.000998	CcSEcCtD
Timolol—Rash—Methotrexate—esophageal cancer	0.000207	0.00099	CcSEcCtD
Timolol—Dermatitis—Methotrexate—esophageal cancer	0.000206	0.000989	CcSEcCtD
Timolol—Headache—Methotrexate—esophageal cancer	0.000205	0.000983	CcSEcCtD
Timolol—Nausea—Methotrexate—esophageal cancer	0.000195	0.000932	CcSEcCtD
Timolol—ADRB2—Signaling by GPCR—PDE4D—esophageal cancer	9.06e-05	0.000928	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	8.97e-05	0.000919	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—GNG7—esophageal cancer	8.81e-05	0.000903	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—GNG7—esophageal cancer	8.77e-05	0.000898	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—GNG7—esophageal cancer	8.62e-05	0.000883	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—CXCL2—esophageal cancer	8.55e-05	0.000876	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—WWOX—esophageal cancer	8.49e-05	0.00087	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—CXCL2—esophageal cancer	8.36e-05	0.000857	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—WWOX—esophageal cancer	8.31e-05	0.000851	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—XIAP—esophageal cancer	8.22e-05	0.000842	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FKBP1A—esophageal cancer	8.08e-05	0.000827	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—ANXA1—esophageal cancer	7.95e-05	0.000814	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FKBP1A—esophageal cancer	7.9e-05	0.000809	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—WIF1—esophageal cancer	7.89e-05	0.000809	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	7.83e-05	0.000802	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—ANXA1—esophageal cancer	7.77e-05	0.000796	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CTNNA1—esophageal cancer	7.77e-05	0.000796	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—CXCL2—esophageal cancer	7.76e-05	0.000795	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—SST—esophageal cancer	7.73e-05	0.000792	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CXCL2—esophageal cancer	7.73e-05	0.000791	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—WIF1—esophageal cancer	7.72e-05	0.000791	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	7.61e-05	0.00078	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—CXCL2—esophageal cancer	7.59e-05	0.000778	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—SST—esophageal cancer	7.56e-05	0.000775	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—GHRL—esophageal cancer	7.53e-05	0.000772	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—GHRL—esophageal cancer	7.37e-05	0.000755	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CSNK1A1—esophageal cancer	7.28e-05	0.000746	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PSME1—esophageal cancer	7.22e-05	0.000739	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PSME2—esophageal cancer	7.22e-05	0.000739	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—ANXA1—esophageal cancer	7.22e-05	0.000739	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—ANXA1—esophageal cancer	7.18e-05	0.000736	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CSNK1A1—esophageal cancer	7.13e-05	0.00073	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—ANXA1—esophageal cancer	7.06e-05	0.000723	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—SST—esophageal cancer	7.02e-05	0.000719	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—SST—esophageal cancer	6.99e-05	0.000716	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—BLVRB—esophageal cancer	6.95e-05	0.000712	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SLC52A3—esophageal cancer	6.95e-05	0.000712	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	6.91e-05	0.000708	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—SST—esophageal cancer	6.87e-05	0.000703	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—GHRL—esophageal cancer	6.84e-05	0.000701	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	6.83e-05	0.0007	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PFN1—esophageal cancer	6.81e-05	0.000698	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—GHRL—esophageal cancer	6.81e-05	0.000697	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NOTCH3—esophageal cancer	6.81e-05	0.000697	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	6.8e-05	0.000697	CbGpPWpGaD
Timolol—ABCB1—Metabolism—BLVRB—esophageal cancer	6.79e-05	0.000695	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SLC52A3—esophageal cancer	6.79e-05	0.000695	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—FBXW7—esophageal cancer	6.7e-05	0.000686	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—GHRL—esophageal cancer	6.69e-05	0.000686	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PFN1—esophageal cancer	6.67e-05	0.000683	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—BLVRB—esophageal cancer	6.4e-05	0.000655	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SLC52A3—esophageal cancer	6.4e-05	0.000655	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	6.22e-05	0.000637	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ELMO1—esophageal cancer	6.12e-05	0.000627	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NOTCH2—esophageal cancer	6.11e-05	0.000626	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ELMO1—esophageal cancer	5.99e-05	0.000613	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AKAP13—esophageal cancer	5.98e-05	0.000613	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SLC10A2—esophageal cancer	5.91e-05	0.000606	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CA1—esophageal cancer	5.91e-05	0.000606	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	5.86e-05	0.000601	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AKAP13—esophageal cancer	5.85e-05	0.0006	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CA1—esophageal cancer	5.77e-05	0.000591	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SLC10A2—esophageal cancer	5.77e-05	0.000591	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	5.69e-05	0.000583	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	5.57e-05	0.00057	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HIST1H2BM—esophageal cancer	5.52e-05	0.000566	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PDE4D—esophageal cancer	5.47e-05	0.000561	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CA1—esophageal cancer	5.44e-05	0.000557	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SLC10A2—esophageal cancer	5.44e-05	0.000557	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TGFBR2—esophageal cancer	5.42e-05	0.000555	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CA2—esophageal cancer	5.41e-05	0.000554	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HIST1H2BM—esophageal cancer	5.4e-05	0.000553	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PDE4D—esophageal cancer	5.35e-05	0.000548	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	5.29e-05	0.000542	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CA2—esophageal cancer	5.28e-05	0.000541	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—GNG7—esophageal cancer	5.2e-05	0.000533	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—SMAD4—esophageal cancer	5.13e-05	0.000525	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—GNG7—esophageal cancer	5.09e-05	0.000522	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	5.03e-05	0.000515	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PLCE1—esophageal cancer	5.03e-05	0.000515	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ADH7—esophageal cancer	5.03e-05	0.000515	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CA2—esophageal cancer	4.97e-05	0.00051	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.97e-05	0.000509	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PLCE1—esophageal cancer	4.91e-05	0.000503	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ADH7—esophageal cancer	4.91e-05	0.000503	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—XIAP—esophageal cancer	4.88e-05	0.0005	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	4.87e-05	0.000499	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—XIAP—esophageal cancer	4.77e-05	0.000489	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	4.63e-05	0.000474	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PLCE1—esophageal cancer	4.62e-05	0.000474	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ADH7—esophageal cancer	4.62e-05	0.000474	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CTNNA1—esophageal cancer	4.61e-05	0.000472	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CXCL2—esophageal cancer	4.59e-05	0.00047	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CTNNA1—esophageal cancer	4.51e-05	0.000462	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CXCL2—esophageal cancer	4.49e-05	0.000459	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ADH1B—esophageal cancer	4.41e-05	0.000452	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ADH1B—esophageal cancer	4.3e-05	0.000441	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PSME2—esophageal cancer	4.28e-05	0.000439	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PSME1—esophageal cancer	4.28e-05	0.000439	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ANXA1—esophageal cancer	4.26e-05	0.000437	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—TYMP—esophageal cancer	4.21e-05	0.000432	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.21e-05	0.000431	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—HIF1A—esophageal cancer	4.2e-05	0.00043	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PSME2—esophageal cancer	4.19e-05	0.000429	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PSME1—esophageal cancer	4.19e-05	0.000429	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ANXA1—esophageal cancer	4.17e-05	0.000427	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SST—esophageal cancer	4.15e-05	0.000425	CbGpPWpGaD
Timolol—ABCB1—Metabolism—TYMP—esophageal cancer	4.11e-05	0.000421	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP26A1—esophageal cancer	4.1e-05	0.00042	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SST—esophageal cancer	4.06e-05	0.000416	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ADH1B—esophageal cancer	4.06e-05	0.000415	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NOTCH3—esophageal cancer	4.04e-05	0.000414	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—GHRL—esophageal cancer	4.04e-05	0.000414	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	4.04e-05	0.000413	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—KDR—esophageal cancer	4.01e-05	0.000411	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP26A1—esophageal cancer	4e-05	0.00041	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ALOX15—esophageal cancer	3.99e-05	0.000409	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FBXW7—esophageal cancer	3.98e-05	0.000407	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—GHRL—esophageal cancer	3.95e-05	0.000405	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NOTCH3—esophageal cancer	3.95e-05	0.000405	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.95e-05	0.000404	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ALOX15—esophageal cancer	3.9e-05	0.000399	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FBXW7—esophageal cancer	3.89e-05	0.000398	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—TYMP—esophageal cancer	3.88e-05	0.000397	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTO1—esophageal cancer	3.81e-05	0.00039	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—TPI1—esophageal cancer	3.81e-05	0.00039	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NOTCH1—esophageal cancer	3.78e-05	0.000387	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP26A1—esophageal cancer	3.77e-05	0.000386	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTO1—esophageal cancer	3.72e-05	0.000381	CbGpPWpGaD
Timolol—ABCB1—Metabolism—TPI1—esophageal cancer	3.72e-05	0.000381	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ALOX15—esophageal cancer	3.67e-05	0.000376	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ALDOB—esophageal cancer	3.65e-05	0.000374	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NOTCH2—esophageal cancer	3.62e-05	0.000371	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ALDOB—esophageal cancer	3.57e-05	0.000365	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NOTCH2—esophageal cancer	3.55e-05	0.000363	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GAPDH—esophageal cancer	3.52e-05	0.00036	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—TPI1—esophageal cancer	3.5e-05	0.000359	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTO1—esophageal cancer	3.5e-05	0.000359	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CRABP1—esophageal cancer	3.49e-05	0.000357	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GAPDH—esophageal cancer	3.43e-05	0.000352	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CREBBP—esophageal cancer	3.43e-05	0.000351	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.43e-05	0.000351	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CRABP1—esophageal cancer	3.4e-05	0.000348	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—EGFR—esophageal cancer	3.37e-05	0.000345	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ALDOB—esophageal cancer	3.36e-05	0.000344	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GNG7—esophageal cancer	3.31e-05	0.00034	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.31e-05	0.00034	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GNG7—esophageal cancer	3.24e-05	0.000331	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GAPDH—esophageal cancer	3.23e-05	0.000331	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—PIK3CA—esophageal cancer	3.22e-05	0.00033	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TGFBR2—esophageal cancer	3.22e-05	0.000329	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CRABP1—esophageal cancer	3.21e-05	0.000328	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TGFBR2—esophageal cancer	3.15e-05	0.000322	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ALDH2—esophageal cancer	3.11e-05	0.000318	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NOS3—esophageal cancer	3.07e-05	0.000314	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GNG7—esophageal cancer	3.05e-05	0.000312	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SMAD4—esophageal cancer	3.04e-05	0.000312	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ALDH2—esophageal cancer	3.03e-05	0.000311	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SMAD4—esophageal cancer	2.98e-05	0.000305	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTT1—esophageal cancer	2.95e-05	0.000303	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—PIK3CA—esophageal cancer	2.92e-05	0.000299	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP2A6—esophageal cancer	2.92e-05	0.000299	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.91e-05	0.000298	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTT1—esophageal cancer	2.88e-05	0.000295	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—ERBB2—esophageal cancer	2.87e-05	0.000294	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ALDH2—esophageal cancer	2.86e-05	0.000293	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.85e-05	0.000292	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTGS1—esophageal cancer	2.77e-05	0.000284	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ENO1—esophageal cancer	2.77e-05	0.000284	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PSME1—esophageal cancer	2.73e-05	0.000279	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PSME2—esophageal cancer	2.73e-05	0.000279	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTT1—esophageal cancer	2.72e-05	0.000278	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ENO1—esophageal cancer	2.7e-05	0.000277	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTGS1—esophageal cancer	2.7e-05	0.000277	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.7e-05	0.000277	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP2A6—esophageal cancer	2.69e-05	0.000275	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PSME1—esophageal cancer	2.66e-05	0.000273	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PSME2—esophageal cancer	2.66e-05	0.000273	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ENO1—esophageal cancer	2.55e-05	0.000261	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTGS1—esophageal cancer	2.55e-05	0.000261	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CCND1—esophageal cancer	2.54e-05	0.00026	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PSME2—esophageal cancer	2.51e-05	0.000257	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PSME1—esophageal cancer	2.51e-05	0.000257	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HIF1A—esophageal cancer	2.49e-05	0.000255	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CDKN1A—esophageal cancer	2.45e-05	0.000251	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HIF1A—esophageal cancer	2.44e-05	0.00025	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.38e-05	0.000244	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KDR—esophageal cancer	2.38e-05	0.000244	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP1B1—esophageal cancer	2.35e-05	0.000241	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EP300—esophageal cancer	2.33e-05	0.000239	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KDR—esophageal cancer	2.33e-05	0.000239	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.3e-05	0.000235	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NOTCH1—esophageal cancer	2.24e-05	0.00023	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP19A1—esophageal cancer	2.21e-05	0.000227	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NOTCH1—esophageal cancer	2.19e-05	0.000225	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP1B1—esophageal cancer	2.17e-05	0.000222	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP19A1—esophageal cancer	2.16e-05	0.000221	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP19A1—esophageal cancer	2.04e-05	0.000209	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CREBBP—esophageal cancer	2.03e-05	0.000208	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MYC—esophageal cancer	2.03e-05	0.000208	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—HMOX1—esophageal cancer	2.02e-05	0.000207	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—EGFR—esophageal cancer	2e-05	0.000205	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CREBBP—esophageal cancer	1.99e-05	0.000204	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EGFR—esophageal cancer	1.99e-05	0.000204	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.98e-05	0.000203	CbGpPWpGaD
Timolol—ABCB1—Metabolism—HMOX1—esophageal cancer	1.97e-05	0.000202	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—EGFR—esophageal cancer	1.96e-05	0.0002	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ABCB1—esophageal cancer	1.94e-05	0.000199	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.91e-05	0.000196	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PIK3CA—esophageal cancer	1.87e-05	0.000191	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.86e-05	0.00019	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NOS3—esophageal cancer	1.82e-05	0.000187	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.78e-05	0.000183	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NOS3—esophageal cancer	1.78e-05	0.000183	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CA—esophageal cancer	1.73e-05	0.000178	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CA—esophageal cancer	1.73e-05	0.000177	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ERBB2—esophageal cancer	1.7e-05	0.000175	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CA—esophageal cancer	1.7e-05	0.000174	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TP53—esophageal cancer	1.67e-05	0.000171	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ERBB2—esophageal cancer	1.67e-05	0.000171	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CCND1—esophageal cancer	1.51e-05	0.000154	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CCND1—esophageal cancer	1.47e-05	0.000151	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.47e-05	0.00015	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CDKN1A—esophageal cancer	1.46e-05	0.000149	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CDKN1A—esophageal cancer	1.42e-05	0.000146	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EP300—esophageal cancer	1.39e-05	0.000142	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EP300—esophageal cancer	1.36e-05	0.000139	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CREBBP—esophageal cancer	1.3e-05	0.000133	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CREBBP—esophageal cancer	1.26e-05	0.00013	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MYC—esophageal cancer	1.21e-05	0.000124	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CREBBP—esophageal cancer	1.19e-05	0.000122	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MYC—esophageal cancer	1.18e-05	0.000121	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EGFR—esophageal cancer	1.18e-05	0.000121	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NOS3—esophageal cancer	1.16e-05	0.000119	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EGFR—esophageal cancer	1.16e-05	0.000118	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NOS3—esophageal cancer	1.13e-05	0.000116	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NOS3—esophageal cancer	1.07e-05	0.000109	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTGS2—esophageal cancer	1.06e-05	0.000109	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTGS2—esophageal cancer	1.04e-05	0.000106	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CA—esophageal cancer	1.02e-05	0.000105	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CA—esophageal cancer	1e-05	0.000103	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TP53—esophageal cancer	9.91e-06	0.000102	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTGS2—esophageal cancer	9.76e-06	0.0001	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TP53—esophageal cancer	9.7e-06	9.94e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—EP300—esophageal cancer	8.82e-06	9.04e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—EP300—esophageal cancer	8.61e-06	8.82e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—EP300—esophageal cancer	8.12e-06	8.31e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CA—esophageal cancer	6.53e-06	6.69e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CA—esophageal cancer	6.37e-06	6.53e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CA—esophageal cancer	6e-06	6.15e-05	CbGpPWpGaD
